CASP1 and stroke disorder: An increasing number of evidence has shown that Z-VAD-FMK or AC-YVAD-CMK, caspase-1 inhibitors, could reduce inflammasome activation-mediated inflammatory response and neuronal cell death after stroke (32–34).